Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PRASCEND DIN 02412217

Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: PERGOLIDE (PERGOLIDE MESYLATE)

Health Canada record

Active ingredient(s)PERGOLIDE (PERGOLIDE MESYLATE) 1 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date10-Feb-2014
Current status date10-Jun-2021
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing PERGOLIDE (PERGOLIDE MESYLATE)

DINProductCompanyFormStrengthStatus
01934279PERMAX TAB 0.05MGELI LILLY CANADA INCTabletPERGOLIDE (PERGOLIDE MESYLATE) 0.05 MGCancelled Post Market
01934287PERMAX TAB 0.25MGELI LILLY CANADA INCTabletPERGOLIDE (PERGOLIDE MESYLATE) 0.25 MGCancelled Post Market
01934295PERMAX TAB 1MGELI LILLY CANADA INCTabletPERGOLIDE (PERGOLIDE MESYLATE) 1 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
260462021-06-10New Drug Submission (NDS)CHANGE IN PRODUCT OWNERSHIP
147002013-09-05New Drug Submission (NDS)
Request a quote for PRASCEND

How to read a Canadian DIN record